Skip to main content
Top
Published in: Arthritis Research & Therapy 1/2017

Open Access 01-12-2017 | Research article

Increased serum concentrations of IL-1 beta, IL-21 and Th17 cells in overweight patients with rheumatoid arthritis

Authors: Hirofumi Shoda, Yasuo Nagafuchi, Yumi Tsuchida, Keiichi Sakurai, Shuji Sumitomo, Keishi Fujio, Kazuhiko Yamamoto

Published in: Arthritis Research & Therapy | Issue 1/2017

Login to get access

Abstract

Backgrounds

Obesity is associated with worse disease activity and drug responses in patients with rheumatoid arthritis (RA). However, the immunological mechanisms responsible for the relationship between RA and obesity have not yet been clarified in detail. This study aimed to elucidate the immunological mechanisms contributing to the pathogenesis of RA in overweight patients.

Methods

The frequencies of CD4+ T cell, B cell and monocyte subsets were analyzed in RA (n = 81) and healthy donors (n = 99) by flow cytometry, and were compared between three groups (body mass index (BMI) <20,  ≥20 to 25, >25). Serum cytokines were measured using multiplex ELISA. Gene expression was analyzed by quantitative PCR. Clinical information was extracted from medical records.

Results

The frequencies of T helper (Th)17 (CD4+CD45RA-CXCR5-CXCR3-CCR6+) cells and plasmablasts (PB) were significantly increased in patients with RA with BMI >25. Significant correlation was observed between BMI and Th17 cells in patients with RA. No significant differences in cell frequencies between the three BMI groups were observed in the healthy donors. Serum interleukin (IL)-1β and IL-21 significantly correlated with BMI in RA patients. Gene expression patterns in Th17 cells from overweight patients with RA showed the characteristics of pathogenic Th17 cells.

Conclusions

Quantitative and qualitative changes in Th17 cells were characteristic in overweight patients with RA.
Appendix
Available only for authorised users
Literature
1.
go back to reference Klaasen R, Wijbrandts CA, Gerlag DM, Tak PP. Body mass index and clinical response to infliximab in rheumatoid arthritis. Arthritis Rheum. 2011;63:359–64.CrossRefPubMed Klaasen R, Wijbrandts CA, Gerlag DM, Tak PP. Body mass index and clinical response to infliximab in rheumatoid arthritis. Arthritis Rheum. 2011;63:359–64.CrossRefPubMed
2.
go back to reference Gremese E, Carletto A, Padovan M, Atzeni F, Raffeiner B, Giardina AR, et al. Obesity and reduction of the response rate to anti-tumor necrosis factor alpha in rheumatoid arthritis: an approach to a personalizaed medicine. Arthritis Care Res. 2013;65:94–100.CrossRef Gremese E, Carletto A, Padovan M, Atzeni F, Raffeiner B, Giardina AR, et al. Obesity and reduction of the response rate to anti-tumor necrosis factor alpha in rheumatoid arthritis: an approach to a personalizaed medicine. Arthritis Care Res. 2013;65:94–100.CrossRef
3.
go back to reference Sandberg ME, Bengtsson C, Kallberg H, Kallberg H, Wesley A, Klareskog L, et al. Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis. Ann Rheum Dis. 2014;73:2029–33.CrossRefPubMed Sandberg ME, Bengtsson C, Kallberg H, Kallberg H, Wesley A, Klareskog L, et al. Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis. Ann Rheum Dis. 2014;73:2029–33.CrossRefPubMed
4.
go back to reference Ajeganova S, Andersson ML, Hafstrom I, BARFOT Study Group. Association of obesity with worse disease severity in rheumatoid arthritis as well as with comorbidities: a long-term follow up from disease onset. Arthritis Care Res. 2013;65:78–87.CrossRef Ajeganova S, Andersson ML, Hafstrom I, BARFOT Study Group. Association of obesity with worse disease severity in rheumatoid arthritis as well as with comorbidities: a long-term follow up from disease onset. Arthritis Care Res. 2013;65:78–87.CrossRef
5.
go back to reference van der Helm-wan Mil AHM, van der Kooij SM, Allaart CF, et al. A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis. Ann Rheum Dis. 2008;67:769–74.CrossRef van der Helm-wan Mil AHM, van der Kooij SM, Allaart CF, et al. A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis. Ann Rheum Dis. 2008;67:769–74.CrossRef
6.
go back to reference Iannone F, Lopalco G, Rigante D, Orlando I, Cantarini L, Lapadula G. Impact of obesity on the clinical outcome of rheumatological patients in biotherapy. Autoimmune Rev. 2016;15:447–50.CrossRef Iannone F, Lopalco G, Rigante D, Orlando I, Cantarini L, Lapadula G. Impact of obesity on the clinical outcome of rheumatological patients in biotherapy. Autoimmune Rev. 2016;15:447–50.CrossRef
7.
go back to reference Nagafuchi Y, Shoda H, Sumitomo S, Nakachi S, Kato R, Tsuchida Y, et al. Immunophenotyping of rheumatoid arthritis reveals a linkage between HLA-DRB1 genotype, CXCR4 expression on memory CD4+ T cells, and disease activity. Sci Rep. 2016;6:29338.CrossRefPubMedPubMedCentral Nagafuchi Y, Shoda H, Sumitomo S, Nakachi S, Kato R, Tsuchida Y, et al. Immunophenotyping of rheumatoid arthritis reveals a linkage between HLA-DRB1 genotype, CXCR4 expression on memory CD4+ T cells, and disease activity. Sci Rep. 2016;6:29338.CrossRefPubMedPubMedCentral
8.
go back to reference Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580–8.CrossRefPubMed Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580–8.CrossRefPubMed
9.
go back to reference Maecker HT, McCoy JP, Nussenblatt R. Standardizing immunophenotyping for the Human Immunology Project. Nat Rev Immunol. 2012;12:191–200.PubMedPubMedCentral Maecker HT, McCoy JP, Nussenblatt R. Standardizing immunophenotyping for the Human Immunology Project. Nat Rev Immunol. 2012;12:191–200.PubMedPubMedCentral
10.
go back to reference Nistala K, Adams S, Cambrook H, Urse S, Olivito B, de Jager W, et al. Th17 plasticity in human autoimmune arthritis is derived by the inflammatory environment. Proc Natl Acad Sci U S A. 2010;107:14751–6.CrossRefPubMedPubMedCentral Nistala K, Adams S, Cambrook H, Urse S, Olivito B, de Jager W, et al. Th17 plasticity in human autoimmune arthritis is derived by the inflammatory environment. Proc Natl Acad Sci U S A. 2010;107:14751–6.CrossRefPubMedPubMedCentral
11.
go back to reference Paulissen SMJ, van Hamburg JP, Davelaar N, Vroman H, Hazes JMW, de Jong PHP, et al. CCR6+Th cell populations distinguish ACPA positive and ACPA negative rheumatoid arthritis. Arthritis Res Ther. 2015;17:344.CrossRefPubMedPubMedCentral Paulissen SMJ, van Hamburg JP, Davelaar N, Vroman H, Hazes JMW, de Jong PHP, et al. CCR6+Th cell populations distinguish ACPA positive and ACPA negative rheumatoid arthritis. Arthritis Res Ther. 2015;17:344.CrossRefPubMedPubMedCentral
12.
go back to reference Lee Y, Awasthi A, Yosef N, Quintana FJ, Xiao S, Peters A, et al. Induction and molecular signature of pathogenic Th17 cells. Nat Immunol. 2012;13:991–9.CrossRefPubMedPubMedCentral Lee Y, Awasthi A, Yosef N, Quintana FJ, Xiao S, Peters A, et al. Induction and molecular signature of pathogenic Th17 cells. Nat Immunol. 2012;13:991–9.CrossRefPubMedPubMedCentral
13.
go back to reference Weyand CM, McCarthy TG, Goronzy JJ. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest. 1995;95:2120–6.CrossRefPubMedPubMedCentral Weyand CM, McCarthy TG, Goronzy JJ. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest. 1995;95:2120–6.CrossRefPubMedPubMedCentral
14.
go back to reference Moots RJ, Naisbett-Groet B. The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor inhibitors: a systematic review. Rheumatoogy. 2012;51:2252–61.CrossRef Moots RJ, Naisbett-Groet B. The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor inhibitors: a systematic review. Rheumatoogy. 2012;51:2252–61.CrossRef
15.
go back to reference Shen H, Goodall JC, Gaston JSH. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum. 2009;60:1647–56.CrossRefPubMed Shen H, Goodall JC, Gaston JSH. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum. 2009;60:1647–56.CrossRefPubMed
16.
go back to reference Cavalli G, Dinarello CA. Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies. Rheumatology (Oxford). 2015;54:2134–44. Cavalli G, Dinarello CA. Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies. Rheumatology (Oxford). 2015;54:2134–44.
17.
go back to reference Niu X, He D, Zhang X, Yue T, Li N, Zhang JZ, et al. IL-21 regulates Th17 cells in rheumatoid arthritis. Hum Immunol. 2010;71:334–41.CrossRefPubMed Niu X, He D, Zhang X, Yue T, Li N, Zhang JZ, et al. IL-21 regulates Th17 cells in rheumatoid arthritis. Hum Immunol. 2010;71:334–41.CrossRefPubMed
18.
go back to reference van den Berg WB, Mclnnes IB. Th17 cells and IL-17 focus on immunopathogenesis and immunotherapeutics. Semin Arthritis Rheum. 2013;43:158–70.CrossRefPubMed van den Berg WB, Mclnnes IB. Th17 cells and IL-17 focus on immunopathogenesis and immunotherapeutics. Semin Arthritis Rheum. 2013;43:158–70.CrossRefPubMed
19.
go back to reference Rho YH, Solus J, Sokka T, Oeser A, Chung CP, Gebretsadik T, et al. Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rhuem. 2009;60:1906–14.CrossRef Rho YH, Solus J, Sokka T, Oeser A, Chung CP, Gebretsadik T, et al. Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rhuem. 2009;60:1906–14.CrossRef
20.
go back to reference Deng J, Liu Y, Yang M, Wang S, Zhang M, Wang X, et al. Leptin exacerbates collagen-induced arthritis via enhancement of Th17 cell response. Arthritis Rheum. 2012;64:3564–73.CrossRefPubMed Deng J, Liu Y, Yang M, Wang S, Zhang M, Wang X, et al. Leptin exacerbates collagen-induced arthritis via enhancement of Th17 cell response. Arthritis Rheum. 2012;64:3564–73.CrossRefPubMed
21.
go back to reference Osborne LC, Joyce KL, Alenghat T, Sonnenberg GF, Giacomin PR, Du Y, et al. Resistin-like molecule α promotes pathogenic Th17 cell responses and bacterial-induced intestinal inflammation. J Immunol. 2013;190:2292–300.CrossRefPubMedPubMedCentral Osborne LC, Joyce KL, Alenghat T, Sonnenberg GF, Giacomin PR, Du Y, et al. Resistin-like molecule α promotes pathogenic Th17 cell responses and bacterial-induced intestinal inflammation. J Immunol. 2013;190:2292–300.CrossRefPubMedPubMedCentral
22.
go back to reference Gómez R, Conde J, Scotece M, Gómez-Reino JJ, Lago F, Gualillo O. What’s new in our understanding of the role of adipokines in rheumatic diseases? Nat Rev Rheumatol. 2011;7:528–36.CrossRefPubMed Gómez R, Conde J, Scotece M, Gómez-Reino JJ, Lago F, Gualillo O. What’s new in our understanding of the role of adipokines in rheumatic diseases? Nat Rev Rheumatol. 2011;7:528–36.CrossRefPubMed
23.
go back to reference Stelzner K, Herbert D, Popkova Y, Lorz A, Schiller J, Gericke M, et al. Free fatty acids sensitize dendritic cells to amplify TH1/TH17-immune responses. Eur J Immunol. 2016;46:2043–53.CrossRefPubMed Stelzner K, Herbert D, Popkova Y, Lorz A, Schiller J, Gericke M, et al. Free fatty acids sensitize dendritic cells to amplify TH1/TH17-immune responses. Eur J Immunol. 2016;46:2043–53.CrossRefPubMed
24.
go back to reference Vandanmagsar B, Youm YH, Ravssin A, Galgani JE, Stadler K, Mynatt RL, et al. The NALP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med. 2011;17:179–88.CrossRefPubMedPubMedCentral Vandanmagsar B, Youm YH, Ravssin A, Galgani JE, Stadler K, Mynatt RL, et al. The NALP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med. 2011;17:179–88.CrossRefPubMedPubMedCentral
25.
go back to reference Jhun JY, Yoon BY, Park MK, Oh HJ, Byun JK, Lee SY, et al. Obesity aggravates the joint inflammation in a collagen-induced arthritis model through deviation to Th17 differentiation. Exp Mol Med. 2012;44:424–31.CrossRefPubMedPubMedCentral Jhun JY, Yoon BY, Park MK, Oh HJ, Byun JK, Lee SY, et al. Obesity aggravates the joint inflammation in a collagen-induced arthritis model through deviation to Th17 differentiation. Exp Mol Med. 2012;44:424–31.CrossRefPubMedPubMedCentral
26.
go back to reference Mclnnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Eng J Med. 2011;365:2205–19.CrossRef Mclnnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Eng J Med. 2011;365:2205–19.CrossRef
27.
go back to reference van Hamburg JP, Asmawidjaja PS, Davelaar N, Mus AM, Colin EM, Hazes JM, et al. Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production. Arthritis Rheum. 2011;63:73–83.CrossRefPubMed van Hamburg JP, Asmawidjaja PS, Davelaar N, Mus AM, Colin EM, Hazes JM, et al. Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production. Arthritis Rheum. 2011;63:73–83.CrossRefPubMed
28.
go back to reference Lee WW, Kang SW, Choi J, Lee SH, Shah K, Eynon EE, et al. Regulating human Th17 cells via differential expression of IL-1 receptor. Blood. 2010;115:530–40.CrossRefPubMedPubMedCentral Lee WW, Kang SW, Choi J, Lee SH, Shah K, Eynon EE, et al. Regulating human Th17 cells via differential expression of IL-1 receptor. Blood. 2010;115:530–40.CrossRefPubMedPubMedCentral
29.
go back to reference Di Minno MN, Peluso R, Iervolino S, Russolillo A, Lupoli R, Scarpa R, CaRRDs Study Group. Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers. Ann Rheum Dis. 2014;73:1157–62.CrossRefPubMed Di Minno MN, Peluso R, Iervolino S, Russolillo A, Lupoli R, Scarpa R, CaRRDs Study Group. Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers. Ann Rheum Dis. 2014;73:1157–62.CrossRefPubMed
Metadata
Title
Increased serum concentrations of IL-1 beta, IL-21 and Th17 cells in overweight patients with rheumatoid arthritis
Authors
Hirofumi Shoda
Yasuo Nagafuchi
Yumi Tsuchida
Keiichi Sakurai
Shuji Sumitomo
Keishi Fujio
Kazuhiko Yamamoto
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/2017
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/s13075-017-1308-y

Other articles of this Issue 1/2017

Arthritis Research & Therapy 1/2017 Go to the issue